Kaitlin Mayne
@kaitlinmayne
Clinical Lecturer in Renal Medicine @UofGSCMH | President @BTPTsociety | @ynptweets UK National Representative 🇬🇧
ID: 1187719250770829313
25-10-2019 13:15:18
1,1K Tweet
797 Followers
1,1K Following
🤩 New snapshot summary on pneumococcal vaccination in patients with reduced kidney function! doi.org/10.1093/ckj/sf… Dustin Le is the YNP author. Prepared by Lauren Floyd. ERA - European Renal Association CKJ
Outstanding editorial from Muthu Vaduganathan GLP-1 receptor agonists in heart failure - The Lancet thelancet.com/journals/lance…
New in NEJM Evidence! Original Article by Jeffrey Ha et al.: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in Kidney Disease eviden.cc/3z2CLzM Sunil Badve Min Jun Swapnil Hiremath @[email protected] Daniel Coyne Suetonia Palmer David C Wheeler Vlado Perkovic The George Institute for Global Health UNSW Medicine & Health
🌟 Are you a young nephrologist looking to unlock the benefits of the Young Nephrologists' Platform? 🎥Tune in to our interview with the YNP Chair-Elect, Safak Mirioglu! 🤝 Learn how you can collaborate and thrive within the YNP of ERA. Full interview 👉 bit.ly/3Gf1XDJ
GLP-1 RA reduces CV events & CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes Our most comprehensive analysis yet, #simpub in Circulation for #ESCCongress ahajournals.org/doi/abs/10.116…
Swe the amazing Effects of Semaglutide on Heart Failure Outcomes in Diabetes and CKD sciencedirect.com/science/articl… Steno Diabetes Center Copenhagen
The FINEHEART Program results, presented by Muthu Vaduganathan now #simpub in Nature medicine nature.com/articles/s4159… #ESCCongress
Whole pop UK linked data on >230,000 ppl with HF from Robert Fletcher at #ESCCongress - Ppl with CKD remain undertreated for HF despite being at 🔼 risk - CKD contributes 2x to 🏥/☠️ than any other comorbidity - Major opportunities to improve pop health In press, The Lancet Public Health